![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis](https://www.mdpi.com/jcm/jcm-10-01274/article_deploy/html/images/jcm-10-01274-g001.png)
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
![Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report](https://www.spandidos-publications.com/article_images/ol/12/3/ol-12-03-1884-g02.jpg)
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?](https://www.frontiersin.org/files/Articles/561146/fimmu-11-02004-HTML/image_m/fimmu-11-02004-g001.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
![Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis](https://www.frontiersin.org/files/Articles/974392/frhem-01-974392-HTML/image_m/frhem-01-974392-g001.jpg)
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
![Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response | Blood Cancer Journal Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-020-00348-5/MediaObjects/41408_2020_348_Fig1_HTML.png)
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response | Blood Cancer Journal
![Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 | Blood Cancer Journal Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-021-00483-7/MediaObjects/41408_2021_483_Fig1_HTML.png)
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 | Blood Cancer Journal
![Cancers | Free Full-Text | Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study Cancers | Free Full-Text | Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study](https://www.mdpi.com/cancers/cancers-13-06017/article_deploy/html/images/cancers-13-06017-g001-550.jpg)
Cancers | Free Full-Text | Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study](https://www.mdpi.com/biomedicines/biomedicines-10-01657/article_deploy/html/images/biomedicines-10-01657-g001-550.jpg)
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
![PDF] Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | Semantic Scholar PDF] Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fb274858d84b05d4516009ea55270acc1e5ed500/5-Figure1-1.png)
PDF] Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | Semantic Scholar
![Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01162-7/MediaObjects/13045_2021_1162_Figa_HTML.png)